Here’s How 23andMe Hopes to Make Drugs from Your Spit Samples

March 16, 2015

(Time) – On March 12, 23andMe, the genetic testing company best known for analyzing your DNA from a sample of spit, announced the creation of a new therapeutics group. The group’s mission: to find and develop drugs from the world’s largest database of human genetic material. That’s a huge shift for the company, which must now build a research and development arm from scratch.